New York State Teachers Retirement System (NYSTRS)’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22M Buy
23,599
+2,004
+9% +$140K ﹤0.01% 1220
2025
Q4
$1.99M Buy
21,595
+505
+2% +$48.3K ﹤0.01% 1117
2025
Q3
$1.56M Sell
21,090
-400
-2% -$40.5K ﹤0.01% 1192
2025
Q2
$2.79M Buy
21,490
+100
+0.5% +$14.5K 0.01% 975
2025
Q1
$3.41M Buy
21,390
+12,196
+133% +$2.21M 0.01% 899
2024
Q4
$1.7M Buy
9,194
+1,100
+14% +$214K ﹤0.01% 1157
2024
Q3
$1.71M Buy
+8,094
New +$1.41M ﹤0.01% 1160

Other funds holding INSP

New York State Teachers Retirement System (NYSTRS)'s INSP Position: Q1 2026 in Review

New York State Teachers Retirement System (NYSTRS) increased its Inspire Medical Systems (INSP) stake by 9.3% in Q1 2026, buying an estimated $140K and bringing the position to 23,599 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

New York State Teachers Retirement System (NYSTRS) first reported a position in INSP in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.41M in Q1 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • New York State Teachers Retirement System (NYSTRS) held 23,599 shares of Inspire Medical Systems worth $1.22M as of Q1 2026.
  • New York State Teachers Retirement System (NYSTRS) bought 2,004 Inspire Medical Systems shares in Q1 2026, an estimated $140K.
  • Inspire Medical Systems made up ﹤0.01% of New York State Teachers Retirement System (NYSTRS)'s portfolio in Q1 2026, its #1220 holding.
  • New York State Teachers Retirement System (NYSTRS) first reported a position in Inspire Medical Systems in Q3 2024 and has held it in 7 quarters since.
  • New York State Teachers Retirement System (NYSTRS)'s Inspire Medical Systems position peaked at $3.41M in Q1 2025.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q1 2026, filed 27 Apr 2026.